DE3269028D1 - Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments - Google Patents

Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments

Info

Publication number
DE3269028D1
DE3269028D1 DE8282201602T DE3269028T DE3269028D1 DE 3269028 D1 DE3269028 D1 DE 3269028D1 DE 8282201602 T DE8282201602 T DE 8282201602T DE 3269028 T DE3269028 T DE 3269028T DE 3269028 D1 DE3269028 D1 DE 3269028D1
Authority
DE
Germany
Prior art keywords
labelled proteins
acid
antibody fragments
radionuclide
particular antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282201602T
Other languages
English (en)
Inventor
Wilhelmus Theodorus Goedemans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Diagnostica Holland BV
Original Assignee
Mallinckrodt Diagnostica Holland BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19838626&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3269028(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mallinckrodt Diagnostica Holland BV filed Critical Mallinckrodt Diagnostica Holland BV
Application granted granted Critical
Publication of DE3269028D1 publication Critical patent/DE3269028D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8282201602T 1981-12-29 1982-12-14 Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments Expired DE3269028D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8105880 1981-12-29

Publications (1)

Publication Number Publication Date
DE3269028D1 true DE3269028D1 (en) 1986-03-20

Family

ID=19838626

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282201602T Expired DE3269028D1 (en) 1981-12-29 1982-12-14 Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments

Country Status (7)

Country Link
EP (1) EP0083129B1 (de)
JP (1) JPS58126817A (de)
AT (1) ATE17825T1 (de)
AU (1) AU562619B2 (de)
CA (1) CA1222691A (de)
DE (1) DE3269028D1 (de)
DK (1) DK574482A (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443426A (en) * 1982-06-14 1984-04-17 Yale University Blood agent
CA1223831A (en) * 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
AU580958B2 (en) * 1983-07-07 1989-02-09 Mallinckrodt, Inc. Sterile radioactive indium-containing aqueous solution
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
US4707352A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
US4897254A (en) * 1984-09-21 1990-01-30 The Dow Chemical Company Radioactive compositions for the treatment of calcific tumors
DE3577550D1 (de) * 1984-09-21 1990-06-13 Dow Chemical Co Aminocarbonsaeurekomplexe zur behandlung von knochentumoren.
EP0210684A1 (de) * 1985-07-31 1987-02-04 MALLINCKRODT, INC.(a Missouri corporation) Ein eine radioaktive Metallzusammensetzung enthaltendes Präparat für Radiodiagnostika
US4732974A (en) * 1986-03-05 1988-03-22 Mallinckrodt, Inc. Metal ion labeling of carrier molecules
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US5021567A (en) * 1987-09-24 1991-06-04 Abbott Laboratories 8-hydroxyquinoline chelating agents
US5245026A (en) * 1987-09-24 1993-09-14 Abbott Laboratories Metal containing 8-hydroxyquinoline chelating agents
US5648471A (en) * 1987-12-03 1997-07-15 Centocor, Inc. One vial method for labeling antibodies with Technetium-99m
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
PT590766E (pt) * 1992-07-31 2000-07-31 Australian Nuclear Science Tec Complexos metalicos de hidroxiarilo contendo agentes quelantes de acido aminocarboxilico
EP0709100A1 (de) * 1994-09-30 1996-05-01 Nihon Medi-Physics Co., Ltd. Kontrastmittel mit mehreren Detektionsgruppen pro Molekül
US7993626B2 (en) * 2007-01-11 2011-08-09 Immunomedics, Inc. Methods and compositions for F-18 labeling of proteins, peptides and other molecules
US7597876B2 (en) * 2007-01-11 2009-10-06 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335095A (en) * 1979-03-21 1982-06-15 The Radiochemical Centre Limited Indium-111 oxine complex composition
JPS56125317A (en) * 1980-03-08 1981-10-01 Nippon Mejifuijitsukusu Kk Stable radioactive diagnosticum with radioactive metallic mark
US4421735A (en) * 1980-04-17 1983-12-20 The Massachusetts General Hospital Radiolabeled diagnostic compositions and method for making the same

Also Published As

Publication number Publication date
EP0083129B1 (de) 1986-02-05
AU562619B2 (en) 1987-06-18
EP0083129A1 (de) 1983-07-06
DK574482A (da) 1983-06-30
ATE17825T1 (de) 1986-02-15
JPS58126817A (ja) 1983-07-28
AU9151082A (en) 1983-07-07
CA1222691A (en) 1987-06-09

Similar Documents

Publication Publication Date Title
DE3269028D1 (en) Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments
US4668503A (en) Process for labeling amines with 99m Tc
US5078985A (en) Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction
JP3070763B2 (ja) テクネチウムまたはレニウムでの抗体または他のタンパク質の直接放射能標識
JP2769244B2 (ja) 蛋白質のテクネチウム／レニウム標識方法
US5514363A (en) Method for radiolabeling antibody fragments
JPS62270600A (ja) キヤリヤ−分子の金属イオン標識化
WO1988007382A2 (en) Method for labelling antibodies with a metal ion
ATE124269T1 (de) Verfahren zur herstellung eines mit metall- radionuklid-markierten proteins.
AU564620B2 (en) Peptides and protein-peptide complexes
US5334708A (en) Method for radiolabeling monovalent antibody fragments
ZA846191B (en) Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp
DE68923093D1 (de) Verfahren zur herstellung von 2,4,6-trijod-5-aminoisophthalsäureamid verbindungen.
ATE106252T1 (de) Verfahren und materialien zur herstellung der lösungen von metallmarkierten antikörpern.
JPH03163097A (ja) タンパク質又はポリペプチドをテクネチウム―９９ｍで標識する方法、生成複合体、画像処理剤としての用途、および複合体の再調製用キット
Neuman et al. The metabolism of labeled parathyroid hormone: II. Methodological studies
US5177192A (en) Method for labeling antibodies with a metal ion
Eshkol Labelling of antigens by various isotopes
TW291440B (en) Gallium dimercaptosuccinate as novel tumor imaging agents
DE68922850D1 (de) Verfahren zur herstellung von 2,4,6-triiodo-5-amino-n-alkyl-isophthalsäure.
US5863517A (en) Process for the preparation of an organ-specific substance labeled with technetium-99m
Harrison Indium chemistry in radiopharmaceutical development
EP0163122A3 (en) Method for the determination of free substances in biological fluids
KR830007543A (ko) 3-아미노메틸렌-2,4-펜탄디온 비스(티오세미카르바존)유도체의 제조법
JP2002322196A (ja) タンパク質またはペプチドの標識方法

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation